By Will Feuer Vertex Pharmaceuticals said the U.S. Food and Drug Administration has approved its Casgevy drug for the treatment of transfusion-dependent beta.
By Sabela Ojea Kyverna Therapeutics is filing for an initial public offering, according to a Securities and Exchange Commission filing. The Emeryville,.
By Ben Glickman Ligand Pharmaceuticals said its treatment for molluscum, a viral skin infection, had received approval from U.S. regulators. The company said.
By Chris Wack Avenue Therapeutics shares were down 29% at 24 cents after the company entered into warrant exercise agreements with existing accredited.